Earnings Feed
Start Free
Home/Filings/4/0001127602-21-011098
4//SEC Filing

Boratto Eva C 4

Accession 0001127602-21-011098

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:22 PM ET

Size

17.4 KB

Accession

0001127602-21-011098

Insider Transaction Report

Form 4
Period: 2021-03-16
CVS HEALTH CorpCVS
Boratto Eva C
SVP, Cont & Chief Acct Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-16$74.29/sh+18,882$1,402,744→ 89,964.045 total
  • Sale

    Common Stock

    2021-03-16$74.68/sh−18,882$1,410,108→ 71,082.045 total
  • Exercise/Conversion

    Stock Option

    2021-03-16−18,882→ 0 total
    Exercise: $74.29From: 2015-04-01Exp: 2021-04-01→ Common Stock (18,882 underlying)
Holdings

  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (27,392 underlying)
    27,392

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (35,030 underlying)
    35,030

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (35,062 underlying)
    35,062

  • Common Stock (restricted)

    3,673

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (21,509 underlying)
    21,509

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (202,007 underlying)
    202,007

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (168,956 underlying)
    168,956
Footnotes (10)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F10]Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
  • [F2]Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.49 and $75.00 per share.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2015.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F5]Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F9]The number of shares subject to the option were calculated using a 30-day average price.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001580827

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:22 PM ET
Size
17.4 KB
View on SEC.gov